Scapho 150

Product Details:

Scapho 150mg (secukinumab) injection is used to treat several chronic autoimmune and inflammatory conditions by reducing pain, swelling, and redness.
Its primary uses are:
Moderate to severe plaque psoriasis: A skin condition that causes red, scaly, and itchy patches on the skin.
Active psoriatic arthritis: A form of arthritis that affects people with psoriasis, causing joint pain, stiffness, and swelling.
Active ankylosing spondylitis: A type of arthritis that primarily affects the spine, causing chronic pain and stiffness in the back and larger joints.
Active non-radiographic axial spondyloarthritis: An inflammatory condition affecting the spine and sacroiliac joints with objective signs of inflammation but without changes visible on standard X-rays.
Enthesitis-related arthritis (ERA): A type of juvenile idiopathic arthritis (in patients aged 4 years and older) that causes inflammation where tendons and ligaments attach to bone.
Moderate to severe hidradenitis suppurativa (HS): A chronic skin condition causing painful lumps and abscesses.
Scapho works by blocking the activity of a protein called interleukin-17A (IL-17A), which is involved in the body's inflammatory responses.
Important Information:
Scapho 150mg is typically administered by a healthcare professional as a subcutaneous injection, though a patient or caregiver may be trained to do it at home.
It may take several months for the full effect of the medication to be seen.
You should not receive live vaccines while undergoing treatment with Scapho.
Before starting treatment, your doctor should screen you for tuberculosis (TB) and other infections.
It is vital to inform your doctor about all medical conditions and any other medications you are taking to avoid potential interactions.